BHVN—FDA approves NURTEC (rimegepant) for acute migraine: https://finance.yahoo.com/news/biohavens-nurtec-odt-rimegepant-receives-211100030.html Nurtec is a CGRP antagonist formulated as an orally disintegrating tablet. The CGRP/migraine market has become crowded.